EPI Health, a Novan Company, and MC2 Therapeutics Announce Data from Survey Conducted by ...
bdtonline.com
news
2022-10-21 12:35:55

DURHAM, N.C. and COPENHAGEN, Denmark, Oct. 21, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. ('the Company' or 'Novan') (Nasdaq: NOVN), EPI Health, a Novan Company, and MC2 Therapeutics today announced that data from a 17-question survey sponsored by the Company was published in a poster entitled, ' Improving Patient Acceptability and Adherence in Psoriasis Treatment,' at the 42nd Annual Fall Clinical Dermatology ConferenceÂ® taking place October 20-23, 2022, in Las Vegas, NV.'Topical medications continue to be a mainstay of psoriasis treatment and results from this survey provide valuable insights into what attributes patients value in these medications.
